Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Core Insights - The Law Offices of Frank R. Cruz is investigating Zimmer Biomet Holdings, Inc. for potential violations of federal securities laws on behalf of investors [1] - Zimmer reported third quarter 2025 financial results with net sales of approximately $2 billion, citing weaknesses in Latin America, Emerging Markets in Europe, and non-core businesses [2] - The company lowered its full-year organic revenue growth forecast from 4.5% to 4.0% due to ongoing weakness in restorative therapies and a slowdown in the U.S. revision market for hips and knees [2] - Following the financial results announcement, Zimmer's stock price dropped by $15.63, or 15.2%, closing at $87.55 per share, impacting investors negatively [2]